Investor Presentaiton
Life sciences¹
Viread, a successful antiviral drug for
the treatment of HIV/AIDS has been
developed at the Czech Academy
of Science's Institute of Organic
Chemistry and Biochemistry.
The country offers a growing network of re-
search clusters, state-of-the-art research facili-
ties, attractive locations for manufacturing and
contract R&D operations plus effective patent
protection. The government's policy goals in-
clude the continuation of R&D support. GMP,
GLP and GCP standards have been adopted.
Current successful investors:
Sanofi, TEVA, Lonza, Otsuka
Nanotechnologies and materials¹
The Czech Republic is proud of its
network of collaborating business
companies which has emerged around
top research institutions involved in the
most prestigious projects.
CEITEC, the Regional Centre of Advanced Tech
nologies and Materials, the Technical Univer-
sity of Liberec are undisputedly world-class
centres of nanotechnology research. They are
supported by a state-of-the-art research infra-
structure and by the Czech Nanotechnology
Cluster and Nanotechnology for Society fund-
ing programme.
Current successful investors:
Microsoft, Skype, NetSuite, Tieto, Red Hat, So
larWinds and IBM
15
1 Investment Climate in the Czech Republic, 2015, CzechInvestView entire presentation